Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3486012rdf:typepubmed:Citationlld:pubmed
pubmed-article:3486012lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3486012lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:3486012lifeskim:mentionsumls-concept:C0023467lld:lifeskim
pubmed-article:3486012lifeskim:mentionsumls-concept:C0079460lld:lifeskim
pubmed-article:3486012lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3486012lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:3486012pubmed:issue5lld:pubmed
pubmed-article:3486012pubmed:dateCreated1986-6-6lld:pubmed
pubmed-article:3486012pubmed:abstractTextProliferation of acute myeloblastic leukemia (AML) cells in vitro is limited in most cases to a small subset of blasts that have several properties of stem cells. These leukemic colony-forming cells (AML-CFU) generally require addition of exogenous growth factors for proliferation in agar or methylcellulose. These factors can be supplied by media conditioned by phytohemagglutinin-stimulated normal leukocytes or by CSF-secreting tumor cell lines. However, the exact factor or factors required for stimulation of AML-CFU growth have not been defined. We compared the AML-CFU stimulatory activity of a human recombinant GM-CSF with that of GCT-CM, Mo-CM, and the PHA-leukocyte feeder system in 15 cases of AML. In each of the 12 cases that required exogenous growth factors for maximum AML-CFU growth, recombinant GM-CSF could replace either GM-CSF or Mo-CM, and could partially replace the PHA-leukocyte feeder system. These results indicate that this GM-CSF is a growth promoter of AML-CFU in these culture systems.lld:pubmed
pubmed-article:3486012pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3486012pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3486012pubmed:languageenglld:pubmed
pubmed-article:3486012pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3486012pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3486012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3486012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3486012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3486012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3486012pubmed:statusMEDLINElld:pubmed
pubmed-article:3486012pubmed:monthMaylld:pubmed
pubmed-article:3486012pubmed:issn0006-4971lld:pubmed
pubmed-article:3486012pubmed:authorpubmed-author:WagnerKKlld:pubmed
pubmed-article:3486012pubmed:authorpubmed-author:YoungDDlld:pubmed
pubmed-article:3486012pubmed:authorpubmed-author:HerrmannFFlld:pubmed
pubmed-article:3486012pubmed:authorpubmed-author:GriffinJ DJDlld:pubmed
pubmed-article:3486012pubmed:authorpubmed-author:SabbathK DKDlld:pubmed
pubmed-article:3486012pubmed:authorpubmed-author:WiperDDlld:pubmed
pubmed-article:3486012pubmed:issnTypePrintlld:pubmed
pubmed-article:3486012pubmed:volume67lld:pubmed
pubmed-article:3486012pubmed:ownerNLMlld:pubmed
pubmed-article:3486012pubmed:authorsCompleteYlld:pubmed
pubmed-article:3486012pubmed:pagination1448-53lld:pubmed
pubmed-article:3486012pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:meshHeadingpubmed-meshheading:3486012-...lld:pubmed
pubmed-article:3486012pubmed:year1986lld:pubmed
pubmed-article:3486012pubmed:articleTitleEffects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblastic leukemia.lld:pubmed
pubmed-article:3486012pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3486012pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3486012pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3486012lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3486012lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3486012lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3486012lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3486012lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3486012lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3486012lld:pubmed